科研速递论坛

标题: Final overall survival results from a randomised, Phase III study of erlotini... [打印本页]

作者: anachronism 时间: 2015-7-6 10:31
标题: Final overall survival results from a randomised, Phase III study of erlotini...

题名	Final overall survival results from a randomised, Phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802).
链接	http://annonc.oxfordjournals.org/content/early/2015/07/03/annonc.mdv276.full.pdf+html

作者: thesea 时间: 2015-7-6 10:31
http://1000eb.com/1e2kw

作者: thesea 时间: 2015-7-6 10:40
111111111111

欢迎光临科研速递论坛 (http://www.expaper.cn/)